Patient satisfaction with the BETACONNECT™ autoinjector for interferon beta-1b

PURPOSE: Multiple sclerosis (MS) is a chronic demyelinating, degenerative disease requiring long-term treatment. Patient adherence to treatment may be challenging in such scenarios, especially since treatment often involves self-injection, for example, with interferon beta-1b during therapy. BETACON...

Descripción completa

Detalles Bibliográficos
Autores principales: Weller, Ivonne, Saake, Anna, Schreiner, Thomas, Vogelreuter, Julika, Petroff, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4501165/
https://www.ncbi.nlm.nih.gov/pubmed/26185425
http://dx.doi.org/10.2147/PPA.S85917

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4501165/
https://www.ncbi.nlm.nih.gov/pubmed/26185425
http://dx.doi.org/10.2147/PPA.S85917

Ejemplares similares